Literature DB >> 8679454

Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy.

G Kick1, G Messer, G Plewig, P Kind, A E Goetz.   

Abstract

Photodynamic therapy (PDT) is currently under investigation in phase II and III clinical studies for the treatment of tumours in superficial localisations. Thus far, the underlying mechanisms of PDT regarding cellular responses and gene regulation are poorly understood. Photochemically generated singlet oxygen (1O2) is mainly responsible for cytotoxicity induced by PDT. If targeted cells are not disintegrated, photo-oxidative stress leads to transcription and translation of various stress response and cytokine genes. Tumour necrosis factor (TNF) alpha, interleukin (IL) 1 and IL-6 are strongly induced by photodynamic treatment, supporting inflammatory action and immunological anti-tumour responses. To investigate the first steps of gene activation, this study focused on the proto-oncogenes c-jun and c-fos, both coding for the transcription factor activator protein 1 (AP-1), which was found to mediate IL-6 gene expression. We here determine the effects of photodynamic treatment on transcriptional regulation and DNA binding of transcription factor AP-1 in order to understand the modulation of subsequent regulatory steps. Photodynamic treatment of epithelial HeLa cells was performed by incubation with Photofrin and illumination with 630 nm laser light in vitro. Expression of the c-jun and c-fos genes was determined by way of Northern blot analysis, and DNA-binding activity of the transcription factor AP-1 was evaluated by electrophoretic mobility shift assay (EMSA). Photofrin-mediated photosensitisation of HeLa cells resulted in a rapid and dose-dependent induction of both genes but preferential expression of c-jun. Compared with the transient expression of c-jun and c-fos by phorbol ester stimulation, photodynamic treatment led to a prolonged activation pattern of both immediate early genes. Furthermore, mRNA stability studies revealed an increased half-life of c-jun and c-fos transcripts resulting from photosensitisation. Although mRNA accumulation after PDT was stronger and more prolonged compared with phorbol ester stimulation, with regard to AP-1 DNA-binding activity, phorbol ester was more efficient. Surprisingly, in addition to the activation of AP-1 DNA-binding via PDT, photodynamic treatment can decrease AP-1 DNA-binding of other strong inducers, such as the protein kinase C-mediated pathway of phorbol esters and the antioxidant pyrrolidine dithiocarbamate (PDTC). This study demonstrates a strong induction of c-jun and c-fos expression by PDT, with prolonged kinetics and mRNA stabilisation as compared with activation by phorbol esters. Interestingly, this observation is not coincident with an overinduction of AP-1 DNA-binding, hence suggesting that post-translational modifications are dominant regulatory mechanisms after PDT that tightly control AP-1 activity in the nucleus thus limiting the risk of deregulated oncogene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679454      PMCID: PMC2074600          DOI: 10.1038/bjc.1996.311

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  61 in total

1.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.

Authors:  T J Bos; F S Monteclaro; F Mitsunobu; A R Ball; C H Chang; T Nishimura; P K Vogt
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

2.  Redox regulation of fos and jun DNA-binding activity in vitro.

Authors:  C Abate; L Patel; F J Rauscher; T Curran
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element.

Authors:  L B Ivashkiv; H C Liou; C J Kara; W W Lamph; I M Verma; L H Glimcher
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

5.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

Authors:  O I Aruoma; B Halliwell; B M Hoey; J Butler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

6.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.

Authors:  S Evans; W Matthews; R Perry; D Fraker; J Norton; H I Pass
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

7.  Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation.

Authors:  Y Manome; R Datta; N Taneja; T Shafman; E Bump; R Hass; R Weichselbaum; D Kufe
Journal:  Biochemistry       Date:  1993-10-12       Impact factor: 3.162

8.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.

Authors:  A D Miller; T Curran; I M Verma
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

10.  Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene.

Authors:  F Meijlink; T Curran; A D Miller; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

View more
  17 in total

1.  Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes.

Authors:  S O Gollnick; B Y Lee; L Vaughan; B Owczarczak; B W Henderson
Journal:  Photochem Photobiol       Date:  2001-02       Impact factor: 3.421

2.  PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells.

Authors:  Chuntao Dan; Niharika Nath; Muriel Liberto; Audrey Minden
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Singlet oxygen generation by UVA light exposure of endogenous photosensitizers.

Authors:  Jürgen Baier; Tim Maisch; Max Maier; Eva Engel; Michael Landthaler; Wolfgang Bäumler
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

Review 4.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

6.  The delayed induction of c-jun in apoptotic human leukemic lymphoblasts is primarily transcriptional.

Authors:  F Zhou; R D Medh; W Zhang; N H Ansari; E B Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2000-12-15       Impact factor: 4.292

7.  Photodynamic therapy induces interleukin secretion from dendritic cells.

Authors:  Toshihiro Kushibiki; Takako Tajiri; Yutaka Tomioka; Kunio Awazu
Journal:  Int J Clin Exp Med       Date:  2010-04-25

8.  Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.

Authors:  K Riesbeck; A Forsgren; A Henriksson; A Bredberg
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment.

Authors:  María Florencia Pansa; María Julia Lamberti; Ingrid Sol Cogno; Silvia Graciela Correa; Natalia Belén Rumie Vittar; Viviana Alicia Rivarola
Journal:  Tumour Biol       Date:  2015-08-01

10.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.

Authors:  D Nowis; M Legat; T Grzela; J Niderla; E Wilczek; G M Wilczynski; E Głodkowska; P Mrówka; T Issat; J Dulak; A Józkowicz; H Waś; M Adamek; A Wrzosek; S Nazarewski; M Makowski; T Stokłosa; M Jakóbisiak; J Gołab
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.